These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 16316613)
1. Erythropoietin use in critically ill patients: forest and trees. Corwin HL CMAJ; 2007 Sep; 177(7):747-9. PubMed ID: 17823138 [No Abstract] [Full Text] [Related]
2. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Park HC; Janjan NA; Mendoza TR; Lin EH; Vadhan-Raj S; Hundal M; Zhang Y; Delclos ME; Crane CH; Das P; Wang XS; Cleeland CS; Krishnan S Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):775-81. PubMed ID: 19231100 [TBL] [Abstract][Full Text] [Related]
3. Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes. Gabrilove J; Paquette R; Lyons RM; Mushtaq C; Sekeres MA; Tomita D; Dreiling L Br J Haematol; 2008 Jul; 142(3):379-93. PubMed ID: 18540943 [TBL] [Abstract][Full Text] [Related]
4. Anemia and transfusions in patients undergoing surgery for cancer. Weber RS; Jabbour N; Martin RC Ann Surg Oncol; 2008 Jan; 15(1):34-45. PubMed ID: 17943390 [TBL] [Abstract][Full Text] [Related]
6. Does TREAT give the boot to ESAs in the treatment of CKD anemia? Singh AK J Am Soc Nephrol; 2010 Jan; 21(1):2-6. PubMed ID: 20035034 [No Abstract] [Full Text] [Related]
7. Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA). Goldsmith D; Covic A Nephrol Dial Transplant; 2010 Jun; 25(6):1734-7. PubMed ID: 20200007 [No Abstract] [Full Text] [Related]